Available in 10 markets
Amundi S&P World Health Care Screened UCITS ETF Acc
Amundi S&P World Health Care Screened UCITS ETF Acc is an exchange-traded fund (ETF) from Amundi, traded under the ticker WEL9 (ISIN IE0006FM6MI8). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. At its core it is a focused, thematic fund: it concentrates on the health care part of the…
Opens the screener with this filter applied.
About this fund
What you own
The S&P World Health Care Weighted & Screened Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 85 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of €100 invested — the line starts at €100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
The 10 biggest holdings make up 52.5% of the fund — the rest is spread across roughly 75 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY & CO | 11.9% |
| 2 | ABBVIE INC | 7.9% |
| 3 | MERCK & CO. INC. | 5.1% |
| 4 | UNITEDHEALTH GROUP INC | 4.8% |
| 5 | NOVARTIS AG-REG | 4.7% |
| 6 | ASTRAZENECA GBP | 4.1% |
| 7 | ROCHE HOLDING AG - GENUSSS CHF | 3.9% |
| 8 | AMGEN INC | 3.9% |
| 9 | GILEAD SCIENCES INC | 3.2% |
| 10 | THERMO FISHER SCIENTIFIC INC | 2.8% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| SIX | WEL9 | CHF | ★ Primary |
| EUR listings | |||
| B3 | GLHLP | EUR | |
| B3 | WELSD | EUR | |
| B3 | WEL9Z | EUR | |
| B3 | WEL9D | EUR | |
| E1 | WEL9EUR | EUR | |
| E1 | WEL9USD | EUR | |
| EB | WELSD | EUR | |
| EB | WEL9D | EUR | |
| EB | GLHLP | EUR | |
| EP | WEL9EUR | EUR | |
| EU | WEL9EUR | EUR | |
| EU | WEL9USD | EUR | |
| Euronext Paris | GLHL | EUR | |
| EZ | WEL9EUR | EUR | |
| Frankfurt | WEL9 | EUR | |
| Frankfurt | WELS | EUR | |
| GD | WELS | EUR | |
| GF | WELS | EUR | |
| GH | WELS | EUR | |
| GM | WELS | EUR | |
| GM | WEL9 | EUR | |
| GS | WELS | EUR | |
| GT | WEL9 | EUR | |
| GT | WELS | EUR | |
| GZ | WEL9 | EUR | |
| I2 | GLHLP | EUR | |
| I2 | WEL9D | EUR | |
| I2 | WELSD | EUR | |
| IX | GLHLP | EUR | |
| IX | WEL9D | EUR | |
| IX | WELSD | EUR | |
| L1 | WELSD | EUR | |
| L1 | WEL9Z | EUR | |
| L1 | WEL9D | EUR | |
| L1 | GLHLP | EUR | |
| L3 | WELSD | EUR | |
| L3 | WEL9Z | EUR | |
| L3 | WEL9D | EUR | |
| L3 | GLHLP | EUR | |
| LA | WELS | EUR | |
| London Stock Exchange | WEL9 | EUR | |
| LU | WELS | EUR | |
| PO | WELSD | EUR | |
| PO | WEL9Z | EUR | |
| PO | WEL9D | EUR | |
| PO | GLHLP | EUR | |
| QT | WELS | EUR | |
| S1 | WELSD | EUR | |
| S1 | WEL9Z | EUR | |
| S1 | WEL9D | EUR | |
| S1 | GLHLP | EUR | |
| S4 | WEL9D | EUR | |
| S4 | WELSD | EUR | |
| S4 | GLHLP | EUR | |
| SE | WEL9 | EUR | |
| TH | WELS | EUR | |
| X1 | WEL9EUR | EUR | |
| X1 | WEL9USD | EUR | |
| X2 | WEL9EUR | EUR | |
| X2 | WEL9USD | EUR | |
| X9 | WEL9EUR | EUR | |
| XA | WEL9EUR | EUR | |
| XA | WEL9USD | EUR | |
| XE | WEL9EUR | EUR | |
| XE | WEL9USD | EUR | |
| XF | WEL9USD | EUR | |
| XF | WEL9EUR | EUR | |
| XG | WEL9EUR | EUR | |
| XG | WEL9USD | EUR | |
| XH | WEL9EUR | EUR | |
| XH | WEL9USD | EUR | |
| XJ | WEL9USD | EUR | |
| XJ | WEL9EUR | EUR | |
| XL | WEL9EUR | EUR | |
| XL | WEL9USD | EUR | |
| XO | WEL9EUR | EUR | |
| XO | WEL9USD | EUR | |
| XQ | WEL9USD | EUR | |
| XQ | WEL9EUR | EUR | |
| XS | WEL9EUR | EUR | |
| XS | WEL9USD | EUR | |
| XT | WEL9EUR | EUR | |
| XT | WEL9USD | EUR | |
| XU | WEL9USD | EUR | |
| XU | WEL9EUR | EUR | |
| XV | WEL9EUR | EUR | |
| XV | WEL9USD | EUR | |
| XW | WEL9EUR | EUR | |
| XW | WEL9USD | EUR | |
| XX | WEL9USD | EUR | |
| XX | WEL9EUR | EUR | |
| XY | WEL9EUR | EUR | |
| XY | WEL9USD | EUR | |
| XZ | WEL9EUR | EUR | |
| XZ | WEL9USD | EUR | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-08-14 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY & CO | 11.9% |
| 2 | ABBVIE INC | 7.9% |
| 3 | MERCK & CO. INC. | 5.1% |
| 4 | UNITEDHEALTH GROUP INC | 4.8% |
| 5 | NOVARTIS AG-REG | 4.7% |
| 6 | ASTRAZENECA GBP | 4.1% |
| 7 | ROCHE HOLDING AG - GENUSSS CHF | 3.9% |
| 8 | AMGEN INC | 3.9% |
| 9 | GILEAD SCIENCES INC | 3.2% |
| 10 | THERMO FISHER SCIENTIFIC INC | 2.8% |
| 11 | INTUITIVE SURGICAL INC | 2.6% |
| 12 | ABBOTT LABORATORIES | 2.4% |
| 13 | VERTEX PHARMACEUTICALS | 2.4% |
| 14 | NOVO NORDISK A/S-B | 2.2% |
| 15 | BRISTOL-MYERS SQUIBB CO | 2.1% |
| 16 | DANAHER CORP | 2.0% |
| 17 | PFIZER INC | 1.9% |
| 18 | MEDTRONIC PLC | 1.8% |
| 19 | STRYKER CORPORATION | 1.8% |
| 20 | MCKESSON CORP | 1.7% |
| 21 | REGENERON PHARMACEUTICALS | 1.4% |
| 22 | ELEVANCE HEALTH INC | 1.3% |
| 23 | BOSTON SCIENTIFIC CORP | 1.3% |
| 24 | CVS HEALTH CORP | 1.3% |
| 25 | THE CIGNA GROUP | 1.2% |
| 26 | SANOFI - PARIS | 1.2% |
| 27 | GSK PLC | 1.0% |
| 28 | EDWARDS LIFESCIENCES CORP | 0.9% |
| 29 | ARGENX SE | 0.9% |
| 30 | CENCORA INC | 0.9% |
| 31 | IDEXX LABORATORIES INC | 0.7% |
| 32 | IQVIA HOLDINGS INC | 0.7% |
| 33 | ALNYLAM PHARMACEUTICALS INC | 0.6% |
| 34 | AGILENT TECHNOLOGIES INC | 0.6% |
| 35 | RESMED INC | 0.6% |
| 36 | XAV HEALTH CARE 09/26 CME | 0.6% |
| 37 | DEXCOM INC | 0.6% |
| 38 | CARDINAL HEALTH INC | 0.5% |
| 39 | UCB SA | 0.5% |
| 40 | TAKEDA PHARMACEUTICAL | 0.5% |
| 41 | HUMANA INC | 0.5% |
| 42 | CHUGAI PHARMACEUTICAL CO LTD | 0.5% |
| 43 | CSL LTD | 0.4% |
| 44 | METTLER-TOLEDO INTERNATIONAL | 0.4% |
| 45 | ZOETIS INC | 0.4% |
| 46 | SANDOZ GROUP AG | 0.4% |
| 47 | GENMAB A/S | 0.4% |
| 48 | HOYA CORP | 0.3% |
| 49 | DAIICHI SANKYO | 0.3% |
| 50 | ASTELLAS PHARMA INC | 0.3% |
| 51 | ESSILORLUXOTTICA | 0.3% |
| 52 | BECTON DICKINSON | 0.3% |
| 53 | ALCON INC - CHF | 0.3% |
| 54 | GE HEALTHCARE TECHNOLOGY | 0.3% |
| 55 | FISHER & PAYKEL HEALTHCARE C | 0.2% |
| 56 | SONOVA HOLDING CHF | 0.2% |
| 57 | STRAUMANN HOLDING AG-REG | 0.2% |
| 58 | STERIS PLC | 0.2% |
| 59 | ICON PLC | 0.2% |
| 60 | SIGMA HEALTHCARE LTD | 0.2% |
| 61 | SHIONOGI & CO LTD | 0.2% |
| 62 | SWEDISH ORPHAN BIOVITRUM AB | 0.2% |
| 63 | ROCHE HOLDING AG-BEARER | 0.2% |
| 64 | ORION OYJ-CLASS B | 0.2% |
| 65 | STOXX 600 HLTH 09/26 EUREX | 0.1% |
| 66 | SIEMENS HEALTHINEERS AG | 0.1% |
| 67 | SMITH & NEPHEW PLC | 0.1% |
| 68 | BIONTECH SE ADR | 0.1% |
| 69 | LONZA GROUP AG-REG | 0.1% |
| 70 | OLYMPUS CORPORATION | 0.1% |
| 71 | ONO PHARMACEUTICAL | 0.1% |
| 72 | COLOPLAST-B | 0.1% |
| 73 | EISAI CO LTD Y50 | 0.1% |
| 74 | RECORDATI INDUSTRIA CHIMICA | 0.1% |
| 75 | COCHLEAR LTD | 0.1% |
| 76 | SARTORIUS PFD | 0.1% |
| 77 | GETINGE AB-B SHS | 0.1% |
| 78 | TEVA PHARMACEUTICAL ADR | 0.1% |
| 79 | SARTORIUS STEDIM BIOTECH | 0.1% |
| 80 | SYSMEX CORPORATION | 0.1% |
| 81 | KYOWA KIRIN CO LTD | 0.1% |
| 82 | SECTRA AB-B SHS SEK | 0.1% |
| 83 | SONIC HEALTHCARE | 0.0% |
| 84 | ASAHI INTECC CO LTD | 0.0% |
| 85 | SANTEN PHARMACEUTICAL CO LTD-OSA | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · Health Care · USD ETFs we track.
Advanced risk
Concentration depth
Roughly 85 companies are held, but the largest names carry most of the weight — so it behaves like ~24 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| Amundi S&P World Health Care Screened UCITS ETF AccAmundiYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksAccumulatingPhysical Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. |
| Index tracked | S&P World Health Care Weighted & Screened Index | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.18% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.18% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.00% |
| Fund size | €647.9M | €166B | €146.5B | €128.1B | €127.6B | €35.6B | €30.7B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +6.5% | +16.8% | +17.8% | +18.3% | +17.8% | ||
| 5-yr return p.a. | +9.7% | +9.3% | +11.3% | +7.1% | |||
| # holdings | 85 | 1,356 | 1,356 | 1,356 | 1,356 | 2,459 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.